This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its unique structure, featuring a cyclopropyl group and a trifluoroethylamine moiety, makes it valuable for developing drugs with specific biological activities, particularly in the areas of central nervous system (CNS) disorders and antimicrobial agents. The trifluoroethyl group enhances the metabolic stability and bioavailability of the resulting compounds, while the cyclopropyl ring contributes to conformational rigidity, which can improve binding affinity to target proteins. Additionally, it is employed in research settings for the development of novel therapeutic agents, including potential treatments for neurological diseases and infections. Its role as a chiral building block also makes it significant in the production of enantiomerically pure drugs, ensuring higher efficacy and reduced side effects.